Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2026-01-09 @ 11:01 AM
Study NCT ID:
NCT00250861
Status:
TERMINATED
Last Update Posted:
2008-04-21
First Post:
2005-11-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Sponsor:
US Oncology Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2007-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-07
First Submit QC Date:
None
Study First Post Date:
2005-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-04-17
Last Update Post Date:
2008-04-21
Last Update Post Date Type:
ESTIMATED